Change Country
Welcome to Denmark
Please read the important information below before continuing to our website

By clicking on your client type to enter the website, you are confirming that you have read and understood the important information that is contained below, and you accept the terms of the Privacy and Cookies policy.


The UCITS ETFs listed on this website are funds under both Amundi ETF and Lyxor ETF denomination.

This website is published by Lyxor International Asset Management (LIAM), a French asset management company approved by the AMF (17 place de la Bourse 75082 Paris Cedex 02) under the UCITS (2009/65/EC) and AIFM (2011/31/EU) directives.

The website is hosted by on Microsoft Azure servers.

This website is subject to French and Danish law.


A professional client is a client that is either a per se professional client or an elective professional client (Note article 4 (1) 12 of Mifid )

Marketing Restrictions and Implications


Lyxor UCITS compliant Exchange Traded Funds (Lyxor UCITS ETFs) referred to on this website are open ended mutual investment funds (i) established under the French law and approved by the Autorité des Marchés Financiers (the French Financial Markets Authority), or (ii) established under the Luxembourg law and approved by the Commission de Surveillance du Secteur Financier (the Luxembourg Financial Supervisory Committee). Most of the protections provided by the Danish regulatory system generally and for funds authorised in Denmark do not apply to these exchange traded funds (ETFs).


This website is exclusively intended for persons who are not "US persons", as such term is defined in Regulation S or the US Securities Act 1933, as amended, and who are not physically present in the US. This website does not constitute an offer or an invitation to purchase any securities in the United States or in any other jurisdiction in which such offer or invitation is not authorised or to any person to whom it is unlawful to make such offer or solicitation. Potential users of this website are requested to inform themselves about and to observe any such restrictions.


Index Replication Process


Lyxor UCITS ETFs follow both physical and synthetic index replication process.


However, most Lyxor UCITS ETFs follow synthetic replication process. This consists of entering into a derivative transaction (a ‘Performance Swap’, as defined below) with a counterparty that provides complete and effective exposure to its benchmark index. Lyxor has adopted this methodology in order to minimise tracking error, optimise transaction costs and reduce operational risks.


A Performance Swap is a contractual agreement which is negotiated over-the-counter (OTC) between two parties: the Lyxor UCITS ETF and its counterparty. From a risk perspective, each Performance Swap ranks equally with other senior unsecured obligations of the counterparty, such as common bonds (i.e., same rights to payments). In the Performance Swap, the counterparty of the Lyxor UCITS ETF commits to pay the Lyxor UCITS ETF a variable return based on a pre-determined benchmark index, instead of a fixed stream of income (as in bonds). At the same time, the counterparty will receive from the Lyxor UCITS ETF the performance and any related revenues generated by the basket's assets (excluding the value of the Performance Swap) held by the Lyxor UCITS ETF. Information provided on individual ETFs includes data on the basket relating to the ETF and the percentage value of the basket represented by each asset. The information is relevant to the closing values on the date given. 


Investment Risks


The Lyxor UCITS ETFs described on this website are not suitable for everyone. Investors' capital is at risk. Investors should not deal in this product unless they understand, having obtained independent professional advice where necessary, its nature, terms and conditions, and the extent of their exposure to risk. The value of the product can go down as well as up and can be subject to volatility due to factors such as price changes in the underlying instrument and interest rates. If a fund is quoted in a different currency to the index, currency risks exist.


Prior to any investment in any Lyxor UCITS ETF, you should make your own appraisal of the risks from a financial, legal and tax perspective, without relying exclusively on the information provided by us. We recommend that you consult your own independent professional advisors (including legal, tax, financial or accounting advisors, as appropriate).


Specific Risks


·         Capital at Risk. ETFs are tracking instruments: Their risk profile is similar to a direct investment in the Benchmark Index. Investors’ capital is fully at risk and investors may not get back the amount originally invested. Investments are not covered by the provisions of the Financial Services Compensation Scheme (“FSCS”), or any similar scheme.

·         Counterparty Risk. Investors may be exposed to risks resulting from the use of an OTC Swap with any counterparty. Physical ETFs may have Counterparty Risk resulting from the use of a Securities Lending Programme.

·         Currency Risk. ETFs may be exposed to currency risk if the ETF or Benchmark Index holdings are denominated in a currency different to that of the Benchmark Index they are tracking. This means that exchange rate fluctuations could have a negative or positive effect on returns.

·         Replication Risk. ETFs are designed to replicate the performance of the Benchmark Index. Unexpected events relating to the constituents of the Benchmark Index may impact the Index provider’s ability to calculate the Benchmark Index, which may affect the ETF’s ability to replicate the Benchmark Index efficiently. This may create Tracking Error in the ETF.

·         Underlying Risk. The Benchmark Index of a Lyxor ETF may be complex and volatile. When investing in commodities, the Benchmark Index is calculated with reference to commodity futures contracts which can expose investors to risks related to the cost of carry and transportation. ETFs exposed to Emerging Markets carry a greater risk of potential loss than investment in Developed Markets as they are exposed to a wide range of unpredictable Emerging Market risks.

·         Liquidity Risk. On-exchange liquidity may be limited as a result of a suspension in the underlying market represented by the Benchmark Index tracked by the ETF; a failure in the systems of one of the relevant stock exchanges, Market Maker systems; or an abnormal trading situation or event.


The securities can be neither offered in nor transferred to the United States.




Any statement in relation to tax, where made, is generic and non-exhaustive and is based on our understanding of the laws and practice in force as of the date of this document and is subject to any changes in law and practice and the interpretation and application thereof, which changes could be made with retroactive effect. Any such statement must not be construed as tax advice and must not be relied upon. The tax treatment of investments will, inter alia, depend on an individual’s circumstances. Investors must consult with an appropriate professional tax adviser to ascertain for themselves the taxation consequences of acquiring, holding and/or disposing of any investments mentioned on this website. 

Further information on the risk factors are available in the Risk Warning section of the website.


Any fund prospectus and supplements are available at Information given about the past performance of the funds is no guarantee of future performance. No investment decision should be taken without reading the fund prospectus and any fund supplement of the fund concerned.


Although the content of the website is based upon information that LIAM consider reliable or comes from sources that LIAM consider reliable, LIAM have not verified such information. Lyxor make no representation or warranty as to the accuracy, completeness or adequacy of any information.  Any reproduction, disclosure or dissemination of the materials available on the website is prohibited.



This website uses cookies to make the website work or improve your user experience. Cookies are small text files that are saved on your computer or device, which are used for several purposes such as detecting preferences and improving site navigation. By continuing to use this website you consent for cookies to be used. For more details, including how to amend your preferences, please read our Cookies Policy.

By clicking on your client type to enter the website, you shall be deemed to have represented to us that you are not a U.S. person and that you are not located in the United States of America, its territories and possessions, and any State of the United States of America and that you are authorised to receive the information to and on this website.

August, 2015




We have a new home

Banner Amundi

Read more
15 May 2019

Is your Robo ETF keeping up with the times?​​

martin ford

The Robotics and AI megatrend is not a new story, but it is one that’s evolving continually. Is your portfolio keeping pace? We spoke to futurist and renowned author Martin Ford1 and our own Head of Innovation, François Millet, to get their views on why industry developments matter and how the Rise of the Robots index adapts to change.

Why does this megatrend matter?

Martin Ford: Put simply, advances in the areas of robotics, automation and artificial intelligence are the biggest things that will happen in the next 10 or 20 years and beyond. They will be a source of incredible economic and societal disruption.

Companies across industries are benefiting from these technologies and are becoming far more efficient as a result. We’re not just talking about the usual IT and Industrials suspects – the impact is apparent in many other areas. Think of the advances in drug discovery by pharmaceutical companies, the automation of trading in financial institutions or the online recommendation engines used by consumer brands – all are increasingly powered by AI. Amazon reportedly has 10,000 employees dedicated solely to their Alexa and Echo technology. The trend is increasingly permeating our daily lives.

The reality is that the companies who will succeed in their respective sectors are the ones leveraging AI. They also have a strong financial incentive to improve their bottom lines through automation and AI. The drivers of change are impossible to ignore, and it’s a unique and incredibly exciting long-term opportunity for investors.

Why buy “builders” and “beneficiaries”?

MF: US tech titans like Alphabet (Google’s parent company), Amazon, and Facebook, as well as Chinese ones like Tencent and Baidu have the dominant positions in the AI field. Alphabet arguably commands the greatest, most powerful concentration of capability and talent that exists. Amazon and Facebook are not too far behind.

These big players are unlikely to cede their ground any time soon, largely because they have both the scale and the expertise to acquire innovative AI startups – Alphabet’s acquisition of DeepMind is a high-profile example. They are prominent examples of “builders” – or indeed “acquirers” – of AI technology. But investing in just some of these big names leaves out a considerable part of the opportunity set. There are hundreds of companies using AI to improve their business models. They are the “beneficiaries”.

Take a health insurance company that owns lots and lots of data about its patients. If a builder like Google supplies AI technology in its cloud server to this beneficiary, the data doesn’t then belong to Google, it still belongs to the insurer. While they may be leveraging Google’s technology, they still own the value of their patients’ data, and they’ll create more value from how they use it.

It’s a mistake to look at AI and say it’s all just Google and Facebook and Tencent, because the value they create ultimately gets distributed to other companies and sectors. From innovation in fintech to drug discovery in biotech, AI is a utility - one which will ultimately scale across and disrupt every industry.

What should we know about the Rise of the Robots index? 

MF: When they designed the Rise of the Robots index, Societe Generale’s Thematic Research team had to address a few challenges. How do you define a universe of relevant stocks that capture the megatrend? How do you target both the builders and the beneficiaries? How do you create a liquid, investable index, and how do you make sure it keeps up with industry trends?

There are three key things to know about the Rise of the Robots index:

1 – It’s big picture investing

We don’t just look at robotics companies, or companies leveraging traditional automation – we search for AI innovators as well. Robotics is certainly a part of AI disruption; it basically amounts to putting the technology into a physical machine. But there is a distinction between the cutting edge of AI and machine learning, and what we see as traditional automation. Robotics clearly has a role to play, but it’s a small part of the bigger picture. AI is much more important to the overall trend. Indices and ETFs which focus too much on traditional robotics risk leaving a lot of value on the table.

2 – It thinks forward

We know the biggest names in AI are the likes of Google, Amazon and Tencent, but the value chain doesn’t end there. It’s important your portfolio tells the full story. AI technologies are transforming banks, media giants, online retailers and healthcare providers to name but a few. AI can and will disrupt companies across the board, so we think forward by including those “beneficiaries” investing for the future, as well as the actual AI “builders”.

3 – It’s designed by man and machine

Robotics, automation and AI technology are evolving at dizzying speed, so we knew we needed a bespoke industry classification to ensure our eligible stock universe kept up with the times. To begin with, we carry out big data analysis across publicly available reports, presentations and meeting transcripts for the terms “Artificial Intelligence” and/or “Robotics” to screen for relevant companies, but unlike most of the other available indices, we don’t stop there. We then do our own digging to ensure other relevant companies are included, often from less obvious sectors such as finance or retail. Relevant IPOs (like Spotify last year) are also considered. We also check for obsolescence or irrelevance - some companies may be acquired by bigger outfits which don’t quite fit our criteria. Others may have started lagging behind in terms of AI and/or robotics investment. This periodic human touch acts as a quality control and is vital to ensure the universe – and by extension, the index – is keeping up with the times.

robo ai

Can you say more about the updates that were made to the index for 2019?

MF: Our annual review of the universe of stocks that are eligible to be included in the index is critical because the field of artificial intelligence is progressing so rapidly and new players are emerging constantly.  Towards the end of 2018, the number of eligible stocks in the universe increased from 210 to 228.  Many of these new companies were listed for the first time. These included high-profile technology IPOs like Spotify and DropBox, but also the security company ADT, digital training company Pluralsight, and many others. Beyond IPOs, we also look for established companies that are demonstrating a strong focus on leveraging AI or robotics in their business models.  For example, we added the Chinese company iFlyTek, which has become as leader in facial recognition technology, and Ocado Group, a UK-based online retailer that has used the latest advances in robotics and automation to develop state-of-the-art distribution centers.

It’s important to note that adding a stock to our universe simply means it becomes eligible to be included in the index. The stocks included and their relative weights within the index are determined entirely systematically and rebalanced each quarter.  This strategy allows us to identify companies with strong potential in the AI/robotics space and add them to the universe early-on.  However, a stock will be selected to be part of the index only when the company generates results that merit inclusion.

Why use Lyxor’s Robotics and AI ETF to capture the theme?

François Millet: Embracing the AI and robotics revolution could help future-proof your portfolio. Our ETF gives you exposure to 150 companies – at least 50% more than other like for like products2 – harnessing the power of AI and robotics, whether for themselves or their customers. And because we want to invest in growing companies that have demonstrated the ability to deliver real results, we screen them based on R&D expenditure on net sales, return on invested capital, and 3-year sales growth. This helps us distinguish between the potential winners and losers.


1Martin Ford is a futurist and the author of three books: Architects of Intelligence: The truth about AI from the people building it (2018), Rise of the Robots: Technology and the Threat of a Jobless Future (2015) and The Lights in the Tunnel: Automation, Accelerating Technology and the Economy of the Future (2009). He is also the founder of a Silicon Valley-based software development firm. His 2017 TED Talk on the impact of AI and robotics on the economy and society has been viewed more than 2 million times. In his role as consultant to Societe Generale, the designer of the ‘Rise of the Robots’ index underlying Lyxor’s ETF, Ford advises on the universe of stocks eligible for index inclusion.
2By “like-for-like”, we refer to European UCITS ETFs that target companies in the fields of both AI and Robotics & Automation.
3Source: Lyxor International Asset Management. Data as at 03/05/2019.

This article is for informative purposes only, and should not be taken as investment advice. Lyxor ETF does not in any way endorse or promote the companies mentioned in this article. The opinions expressed by Martin Ford are his own, and do not necessarily reflect the views of Lyxor International Asset Management or Societe Generale. Capital at risk. Please read our Risk Warning below.

Risk Warning

​This document is for the exclusive use of investors acting on their own account and categorised either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets in Financial Instruments Directive 2014/65/EU. These products comply with the UCITS Directive (2009/65/EC). Société Générale and Lyxor International Asset Management (LIAM) recommend that investors read carefully the “investment risks” section of the product’s documentation (prospectus and KIID). The prospectus and KIID are available free of charge on, and upon request to

Except for the United-Kingdom, where this communication is issued in the UK by Lyxor Asset Management UK LLP, which is authorized and regulated by the Financial Conduct Authority in the UK under Registration Number 435658, this communication is issued by Lyxor International Asset Management (LIAM), a French management company authorized by the Autorité des marchés financiers and placed under the regulations of the UCITS (2014/91/EU) and AIFM (2011/61/EU) Directives. Société Générale is a French credit institution (bank) authorised by the Autorité de contrôle prudentiel et de résolution (the French Prudential Control Authority).

The products mentioned are the object of market-making contracts, the purpose of which is to ensure the liquidity of the products on the London Stock Exchange, assuming normal market conditions and normally functioning computer systems. Units of a specific UCITS ETF managed by an asset manager and purchased on the secondary market cannot usually be sold directly back to the asset manager itself. Investors must buy and sell units on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units and may receive less than the current net asset value when selling them. Updated composition of the product’s investment portfolio is available on In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the product, and might also be mentioned on the websites of the stock exchanges where the product is listed.

Prior to investing in the product, investors should seek independent financial, tax, accounting and legal advice. It is each investor’s responsibility to ascertain that it is authorised to subscribe, or invest into this product. This document is of a commercial nature and not of a regulatory nature. This material is of a commercial nature and not a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor Asset Management (together with its affiliates, Lyxor AM) or any of their respective subsidiaries to purchase or sell the product referred to herein.

Research disclaimer

Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see appendix at the end of this report for the analyst(s) certification(s), important disclosures and disclaimers. Alternatively, visit our global research disclosure website

Conflicts of interest

This research contains the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to (i) ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees.​

Connect with us on linkedin